Albert, F
Research shows that while 50-60% of users experience gastrointestinal side effects initially, these are usually mild to moderate and transient
Massage the Area: Gentle massage of the treated area can help distribute the solution and expedite the fat dissolution process
*GLP-1 peptides offered by LIVation will come from a US based lab, manufacturer, and/or compounding pharmacy, therefore the product is not FDA approved
While injectable GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed the treatment landscape for obesity and type 2 diabetes, their reliance on subcutaneous injection remains a significant barrier to broader adoption
This genetic roadmap helps PlexusDx clinical teams recommend semaglutide, tirzepatide, or the GLP-Squared dual-compound protocol based on your unique peptide pathway profileoptimizing outcomes before your HSA or FSA dollars are spent